- The immunoproteasome is a specialised form of the proteasome found predominantly in immune cells and induced in other cell types during inflammation. It plays a central role in shaping immune responses by generating antigenic peptides for MHC class I presentation and regulating cytokine production, signalling pathways, and inflammatory processes. The immunoproteasome ensures that infected or abnormal cells are efficiently recognised by cytotoxic T lymphocytes, making it indispensable for adaptive immunity and host defence.
- The immunoproteasome is structurally similar to the 20S proteasome but contains three inducible catalytic β‑subunits: β1i (LMP2), β2i (MECL‑1), and β5i (LMP7). These subunits replace the constitutive β‑subunits during assembly, altering the proteolytic activities of the core. As a result, the immunoproteasome produces peptides with hydrophobic C‑termini that bind more efficiently to MHC class I molecules. This modification enhances antigen presentation during infection, inflammation, and cellular stress, ensuring rapid and accurate immune recognition.
- The immunoproteasome is induced by pro‑inflammatory cytokines such as interferon‑γ (IFN‑γ) and tumour necrosis factor‑α (TNF‑α). Under these conditions, cells increase the expression of immunoproteasome subunits and assemble specialised complexes that optimise antigen processing. This adaptive response allows immune cells to generate a diverse and high‑affinity peptide repertoire, improving the detection of viral, bacterial, and tumour antigens.
- Beyond antigen presentation, the immunoproteasome plays a crucial role in regulating inflammatory signalling. It modulates the turnover of key signalling proteins involved in pathways such as NF‑κB, JAK–STAT, and MAPK. By controlling the degradation of these intermediates, the immunoproteasome influences cytokine production, immune cell activation, and the resolution of inflammation. This regulatory function ensures that immune responses are appropriately timed and balanced.
- The immunoproteasome also contributes to protein quality control during oxidative stress. Immune activation generates reactive oxygen species that damage proteins, and the immunoproteasome efficiently degrades oxidised or misfolded proteins to maintain proteostasis. This protective role is essential for immune cell survival and function during infection and inflammation.
- Dysregulation of immunoproteasome activity is associated with several diseases. Excessive immunoproteasome activation contributes to autoimmune disorders such as rheumatoid arthritis, lupus, and multiple sclerosis by promoting chronic inflammation. Conversely, impaired immunoproteasome function weakens antigen presentation and increases susceptibility to infections. In cancer, tumour cells may manipulate immunoproteasome activity to evade immune detection. As a result, immunoproteasome inhibitors and modulators are being explored as therapeutic strategies for autoimmune diseases, inflammatory disorders, and cancer immunotherapy.
- Overall, the immunoproteasome is a specialised and highly adaptive proteolytic complex essential for immune surveillance, antigen processing, and inflammatory regulation. Its unique catalytic properties and inducible nature allow immune cells to respond rapidly and effectively to pathogenic threats. Understanding immunoproteasome biology provides valuable insight into host defence, autoimmunity, and therapeutic innovation.
